期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
Background Gastric cancer (GC) is one of the most common cancers causing a poor prognosis worldwide. HOXA13, as a member of the homeobox (HOX) family,......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
Background Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma, and about 10% of DLBCL cases primarily occur in t......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
Background Patients receiving hematopoietic stem cell transplantation (HSCT) or chimeric antigen receptor T cell (CAR T-cell) therapy are immunocompro......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
Objective Circular RNAs (circRNAs) play a critical role in the modulation of tumor metabolism. However, the expression patterns and metabolic function......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
Taxanes plus carboplatin (TP) regimen may be an acceptable alternative adjuvant chemotherapy strategy in patients with triple-negative breast cancer (......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
Similar to neurodegenerative diseases, the concept that tumors are prion like diseases has been proposed in recent years. p53, the most well-known tum......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
Epithelial cell adhesion molecule (EpCAM) functions not only in physiological processes but also participates in the development and progression of ca......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
Brain metastasis accounts for a large number of cancer-related deaths. The host immune system, involved at each step of the metastatic cascade, plays ......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
Acute myeloid leukemia (AML) is a complex, heterogeneous malignant hematologic disease. Although multiple prognostic-related genes gave been explored ......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
As the most common and abundant RNA modification in eukaryotic cells, N6-methyladenosine (m6A) modification plays an important role in different stage......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
Relapsed/refractory acute myeloid leukemia (AML) patients generally have a dismal prognosis and the treatment remains challenging. Due to the expressi......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
RHO GTPases are a subfamily of the RAS superfamily of proteins, which are highly conserved in eukaryotic species and have important biological functio......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
Metabolic reprogramming, fundamentally pivotal in carcinogenesis and progression of cancer, is considered as a promising therapeutic target against tu......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
The N(6)-methyladenosine (m6A) modification is the most pervasive modification of human RNAs. In recent years, an increasing number of studies have su......
期刊： EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022; 11 (1)
The combination of rituximab, lenalidomide, and Bruton's tyrosine kinase inhibitor (BTKi) ibrutinib, followed by chemotherapy, has shown high efficacy......
